Alvogen and Yas Holding have entered into a binding agreement for the exclusive partnership and distribution to commercialize Alvogen’s targeted generic pharmaceuticals portfolio in the MENA region. The portfolio consists of 28 generic pharmaceuticals in the field of oncology, autoimmune and inflammation and blood diseases that will be brought to market from 2020 and onwards.
Alvogen’s portfolio will be commercialized in the MENA region, including Gulf, KSA, Levant, North Africa and Sub-Saharan Africa.
About Yas Holding Yas Holding is a business development and investment company based in Abu Dhabi in the United Arab Emirates. Active in sectors as diverse as technology, agriculture, healthcare, education and aviation, their breadth of scope is underpinned and strengthened by their commitment to the provision of high value, high quality products and services.
Yas Holding is an agile investment group with a steadfast commitment to partnership and business excellence, with a driving mission to invest in people, technology and diverse industries, to create value for their shareholders and their customers.